Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» M&A
M&A
Valeant to keep specialty Salix reps, but it's eyeing primary care for potential cuts
Fierce Pharma Marketing
Wed, 02/25/15 - 04:14 pm
Valeant Pharmaceuticals
Salix
layoffs
M&A
Ireland's Shire buys Meritage Pharma for $70m
Pharmaceutical Business Review
Wed, 02/25/15 - 09:51 am
Shire
Meritage Pharma
M&A
Salix Suitors May Yet Emerge to Challenge Valeant: Real M&A
Bloomberg
Tue, 02/24/15 - 02:23 pm
Salix
Valeant Pharmaceuticals
M&A
Shire
Takeda
AstraZeneca
AbbVie
Actavis
Endo Health Solutions
Allergan CEO May Get $100 Million for Getting Fired
Bloomberg
Tue, 02/24/15 - 02:14 pm
Allergan
Actavis
M&A
executive pay
David Pyott
Is a weak Eli Lilly ripe for a takeover?
Fierce Biotech
Tue, 02/24/15 - 11:50 am
Eli Lilly
M&A
Takeda makes an M&A move in Turkey
Fierce Pharma
Tue, 02/24/15 - 10:38 am
Takeda
M&A
Turkey
Neutec
Here’s Why Valeant Pharmaceuticals Intl Inc Will Strike More Acquisition Deals In 2015
Bidness Etc.
Tue, 02/24/15 - 09:40 am
Valeant Pharmaceuticals
M&A
Actavis
Allergan
Salix
Shire's shopping spree continues with a $245M deal to buy PhIII-ready Meritage
Fierce Biotech
Tue, 02/24/15 - 09:36 am
Shire
M&A
Meritage Pharma
Salix Pharmaceuticals, Ltd.-Valeant Pharmaceuticals Intl Inc Deal Gets Top Shareholder’s Support
Bidness Etc.
Tue, 02/24/15 - 09:16 am
Salix
Valeant Pharmaceuticals
M&A
Salix Finally Says Yes To Valeant In $158-Per-Share, $10.4 Billion Deal
Seeking Alpha
Mon, 02/23/15 - 05:50 pm
Salix
Valeant Pharmaceuticals
M&A
Valeant to Buy Salix, but Will Another Bidder Emerge? What the Wags Say…
WSJ Pharmalot
Mon, 02/23/15 - 10:57 am
Valeant Pharmaceuticals
Salix
M&A
Shire
Bristol-Myers bags IDO immunotherapy in $1.25B buyout of fledgling Flexus
Fierce Biotech
Mon, 02/23/15 - 09:40 am
Bristol-Myers Squibb
IDO immunotherapy
cancer immunotherapy
Flexus
M&A
Johnson & Johnson reportedly in talks to sell its Cordis unit; Cardinal Health is rumored to be the leading bidder
Bidness Etc.
Mon, 02/23/15 - 08:45 am
JNJ
Cordis
devices
M&A
Cardinal Health
Drugmaker Valeant to buy Salix for $10.1B: Sources
CNBC
Sun, 02/22/15 - 09:30 am
Valeant Pharmaceuticals
Salix
M&A
Drugmaker Valeant close to buying Salix - source
Yahoo/Reuters
Fri, 02/20/15 - 02:57 pm
Salix
M&A
Valeant Pharmaceuticals
Shire
Endo Health Solutions
Bayer may sell diabetes devices unit to KKR-backed Panasonic Health -report
Yahoo/Reuters
Fri, 02/20/15 - 10:19 am
Bayer
diabetes
devices
Panasonic
M&A
Want Actavis? Prepare to pay up, CEO says
Fierce Pharma
Fri, 02/20/15 - 09:18 am
Actavis
Pharma CEOs
Brent Saunders
M&A
Pharma's top 10 M&A deals of 2014
Fierce Pharma
Thu, 02/19/15 - 07:51 am
M&A
Actavis
Allergan
Forest Labs
GSK
Novartis
Bayer
Merck
Cubist Pharma
Roche
InterMune
Mylan Labs
Abbott Labs
Questcor
Mallinckrodt
Eli Lilly
Sun Pharma
Ranbaxy
Actavis CEO says no "transformational" deals for now
Yahoo/Reuters
Wed, 02/18/15 - 04:17 pm
Actavis
Pharma CEOs
Brent Saunders
M&A
Actavis plans name change to Allergan
Yahoo/AP
Wed, 02/18/15 - 08:46 am
Actavis
Allergan
M&A
Pages
« first
‹ previous
…
167
168
169
170
171
172
173
174
175
…
next ›
last »